Today

Agents

Chat

Arena

Discover

More

App

Lexaria regains Nasdaq bid price compliance, avoids delisting hearing - LEXX News | Rallies

Lexaria regains Nasdaq bid price compliance, avoids delisting hearing

LEXX•2026-08-17

Nasdaq compliance regained

Lexaria Bioscience regained Nasdaq compliance with the $1 minimum bid price rule on Aug. 17, 2026.
Nasdaq cancelled the previously requested hearing; the stock will remain listed on the Nasdaq Capital Market.

Related News

UBP sees September Fed hold as US inflation cools further

SPY•2026-08-17

CB Financial Chief Credit Officer Stephen Cobain disposes of 1,500 shares worth $43,684.2

CBFV•2026-08-17

Harmony Gold names Frans “Faan” Lombard lead independent director

Sources

S

Lexaria regains Nasdaq bid price compliance, avoids delisting hearing

Sec

•

2026-08-17

Alpha Cognition Inc. <ACOG.O>: H.C. Wainwright Raises Target Price to $20 From $18

ACOG•2026-08-17

Oil steady on Iran war stalemate

XLE•2026-08-17